Home spirometry for idiopathic pulmonary fibrosis: ready for prime time?

被引：2
作者：
Maher, Toby M. [1 ,2 ]
机构：
[1] Royal Brompton Hosp, NIHR Resp Biomed Res Unit, London, England
[2] Imperial Coll, Natl Heart & Lung Inst, Fibrosis Res Grp, London, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 50卷 / 01期
基金：
美国国家卫生研究院;
关键词：
FORCED VITAL CAPACITY; PIRFENIDONE; NINTEDANIB; EFFICACY;
D O I：
10.1183/13993003.01403-2017
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 10 条
[1]   Efficacy of Mobile Apps to Support the Care of Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J].
Bonoto, Braulio Cezar ;
de Araujo, Vania Eloisa ;
Godoi, Isabella Piassi ;
Pires de Lemos, Livia Lovato ;
Godman, Brian ;
Bennie, Marion ;
Diniz, Leonardo Mauricio ;
Guerra Junior, Augusto Afonso .
JMIR MHEALTH AND UHEALTH, 2017, 5 (03)
[2]   Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis [J].
Johannson, Kerri A. ;
Vittinghoff, Eric ;
Morisset, Julie ;
Lee, Joyce S. ;
Balmes, John R. ;
Collard, Harold R. .
EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (01)
[3]   Forced Vital Capacity in Idiopathic Pulmonary Fibrosis - FDA Review of Pirfenidone and Nintedanib [J].
Karimi-Shah, Banu A. ;
Chowdhury, Badrul A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (13) :1189-1191
[4]   A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis [J].
King, Talmadge E., Jr. ;
Bradford, Williamson Z. ;
Castro-Bernardini, Socorro ;
Fagan, Elizabeth A. ;
Glaspole, Ian ;
Glassberg, Marilyn K. ;
Gorina, Eduard ;
Hopkins, Peter M. ;
Kardatzke, David ;
Lancaster, Lisa ;
Lederer, David J. ;
Nathan, Steven D. ;
Pereira, Carlos A. ;
Sahn, Steven A. ;
Sussman, Robert ;
Swigris, Jeffrey J. ;
Noble, Paul W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22) :2083-2092
[5]  
Lin MH, 2016, MINERVA MED
[6]   Precision medicine in idiopathic pulmonary fibrosis [J].
Maher, T. M. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (09) :585-587
[7]   Idiopathic pulmonary fibrosis [J].
Richeldi, Luca ;
Collard, Harold R. ;
Jones, Mark G. .
LANCET, 2017, 389 (10082) :1941-1952
[8]   Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis [J].
Richeldi, Luca ;
du Bois, Roland M. ;
Raghu, Ganesh ;
Azuma, Arata ;
Brown, Kevin K. ;
Costabel, Ulrich ;
Cottin, Vincent ;
Flaherty, Kevin R. ;
Hansell, David M. ;
Inoue, Yoshikazu ;
Kim, Dong Soon ;
Kolb, Martin ;
Nicholson, Andrew G. ;
Noble, Paul W. ;
Selman, Moises ;
Taniguchi, Hiroyuki ;
Brun, Michele ;
Le Maulf, Florence ;
Girard, Mannaig ;
Stowasser, Susanne ;
Schlenker-Herceg, Rozsa ;
Disse, Bernd ;
Collard, Harold R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22) :2071-2082
[9]   Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis [J].
Russell, Anne-Marie ;
Adamali, Huzaifa ;
Molyneaux, Philip L. ;
Lukey, Pauline T. ;
Marshall, Richard P. ;
Renzoni, Elisabetta A. ;
Wells, Athol U. ;
Maher, Toby M. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (08) :989-997
[10]   Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis [J].
Zappala, C. J. ;
Latsi, P. I. ;
Nicholson, A. G. ;
Colby, T. V. ;
Cramer, D. ;
Renzoni, E. A. ;
Hansell, D. M. ;
du Bois, R. M. ;
Wells, A. U. .
EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (04) :830-835
1